{"id":103628,"date":"2026-10-05T17:06:08","date_gmt":"2026-10-05T17:06:08","guid":{"rendered":"https:\/\/www.europesays.com\/germany\/103628\/"},"modified":"2026-10-05T17:06:08","modified_gmt":"2026-10-05T17:06:08","slug":"bayer-to-invest-2-2-billion-in-ohio-pharmaceutical-manufacturing-site","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/germany\/103628\/","title":{"rendered":"Bayer to invest $2.2 billion in Ohio pharmaceutical manufacturing site"},"content":{"rendered":"<p class=\"featured-image-info\" style=\"font-size: 11px !important; line-height: 1.3 !important; color: #212529; margin: 5px 0;\">Bayer&#8217;s U.S. headquarters in Whippany. &#8211; JHVEPhoto\/Adobe Stock<\/p>\n<p>Bayer, whose U.S. pharmaceutical headquarters is in Whippany, plans to invest $2.2 billion in a new manufacturing site in New Albany, Ohio, to support production of medicines for its growing portfolio.<\/p>\n<p>The company expects the project to create about 600 jobs at the New Albany International Business Park, along with roughly 1,500 construction jobs. The new facility will complement Bayer\u2019s U.S. pharmaceutical headquarters in Whippany and its other U.S. sites, the company said.<\/p>\n<p>The planned campus will combine drug-substance and drug-product manufacturing and use digital and automation technologies. It is designed to support medicines in oncology, cardiovascular and renal care, according to the announcement.<\/p>\n<p><a href=\"https:\/\/www.roi-nj.com\/2026\/09\/10\/healthcare\/bayer-receives-fda-approval-for-first-line-lung-cancer-therapy-hyrnuo\/\" target=\"_blank\" rel=\"noopener nofollow\">Bayer<\/a> expects the first module, for drug-substance manufacturing, to become operational in 2031. A second module, for drug-product manufacturing, is planned to follow in 2034.<\/p>\n<p>The project is part of Bayer\u2019s long-term growth strategy in the United States, which the company described as its largest pharmaceuticals market. Bayer said it has spent more than $7 billion on U.S. pharmaceutical research and development and manufacturing over the past five years.<\/p>\n<p>\u201cBayer has long seen the United States as a key manufacturing base and innovation hub,\u201d CEO Bill Anderson said. He said the new site would add manufacturing expertise and a skilled workforce to help supply medicines to patients in the United States and abroad.<\/p>\n<p>The company said the flexible, modular design is intended to strengthen medicine supply reliability. The announcement did not specify a construction start date or provide further details about the planned workforce.<\/p>\n<p>The site in New Albany will join Bayer\u2019s U.S. pharmaceutical locations in Whippany; Pittsburgh; Berkeley, California; Cambridge, Massachusetts; Research Triangle Park, North Carolina; and San Diego.<\/p>\n","protected":false},"excerpt":{"rendered":"Bayer&#8217;s U.S. headquarters in Whippany. &#8211; JHVEPhoto\/Adobe Stock Bayer, whose U.S. pharmaceutical headquarters is in Whippany, plans to&hellip;\n","protected":false},"author":2,"featured_media":103629,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21161],"tags":[21182,69518,69519,69520,42233,29157,38878,69163,36419,43617,63062,18520],"class_list":["post-103628","post","type-post","status-publish","format-standard","has-post-thumbnail","category-bayer","tag-bayer","tag-bayer-u-s","tag-biopharmaceuticals","tag-drug-manufacturing","tag-job-creation","tag-life-sciences","tag-manufacturing-investment","tag-new-albany-ohio","tag-new-jersey","tag-pharmaceutical-manufacturing","tag-whippany","tag-workforce"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/posts\/103628","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/comments?post=103628"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/posts\/103628\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/media\/103629"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/media?parent=103628"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/categories?post=103628"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/tags?post=103628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}